Studies on RAETL1 in thyroid cells demonstrated that anaplastic cancer cell lines are sensitive to NK cell-mediated lysis via ULBP2/5/6 and chemoattractant CXCR3-positive NK cells, suggesting that patients with ATC may benefit from NK cell-based immunotherapy [20]. The gene discussed is ULBP2; the disease is anaplastic cancer.